Find licenseable technologies 
 from Academic labs, 
 Foundations, and Government 

See the full database

Patent Number: 9,029,550

Conformationally restricted urea inhibitors of soluble epoxide hydrolase

Abstract Inhibitors of the soluble epoxide exemplary hydrolase (sEH) are provided that incorporate multiple pharmacophores and are useful in the treatment of diseases.
Filing Date: June 14, 2013 Issue Date: May 12, 2015 Link: USPTO website

Primary Technology Field

Biotechnology

Other technologies in this field

Biographical Information

Citations

Patents cited by this patent

Patent Title
6,710,043 Amide compounds
6,693,202 Muscarinic receptor antagonists
6,613,572 Agent for expression of long-term potentiation of synaptic transmission comprising compound having brain somatostatin activation property
6,531,506 Inhibitors of epoxide hydrolases for the treatment of hypertension
6,387,900 3(5)-ureido-pyrazole derivatives process for their preparation and their use as antitumor agents
6,344,358 Agent for expression of long-term potentiation of synaptic transmission comprising compound having brain somatostatin activation property
6,335,029 Polymeric coatings for controlled delivery of active agents
6,329,395 Neuropeptide Y5 receptor antagonists
6,322,847 Medical device coating methods and devices
6,299,604 Coated implantable medical device
6,290,722 Tacky attachment method of covered materials on stents
6,287,285 Therapeutic, diagnostic, or hydrophilic coating for an intracorporeal medical device
6,211,241 Aryl sulfonamides and sulfamide derivatives and uses thereof
6,150,415 Epoxide hydrolase complexes and methods therewith
5,962,455 Certain substituted benzylamine derivatives a new class of neuropeptide Y1 specific ligands
`abc
Copyright thinkBiotech LLC. All rights reserved.
Privacy policy.